Bionovate Technologies (BIIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access BIIO quarterly Balance Sheets →
This page allows investors to track Bionovate Technologies's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2021)
(Jun 30 2020) (Jun 30 2019) (Jun 30 2018) (Jun 30 2017)
Assets
Cash & Short-term Investments0.00
Total Current Assets0.00
Total Assets0.00
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.27
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current0.24
Total Current Liabilities0.50
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.50
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2.30
Retained Earnings / Accumulated Deficit-2.80
Other Equity0.00
Common Stockholder's Equity-0.50
Total Stockholder's Equity-0.50
4 historic quarters locked

Sign in to unlock the full Bionovate Technologies balance sheet history.

About BIIO Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.